Safety, Tolerability, and Pharmacokinetics of MK-8266 in Elderly Participants With High Blood Pressure (MK-8266-003)

NCT01263314 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: MK-8266
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC